24results about "Colostomy devices" patented technology

An antimicrobial amphiphilic hydrogel composition for use in haemostasis of a wound comprising: a first cross-linkable amphiphilic component, the first amphiphilic component, in its chemically cross-linked state, being a lyotropic liquid crystal and having an ordered nanostructure of hydrophobic and hydrophilic domains, the hydrogel comprising an antimicrobial agent covalently attached to the hydrophilic and / or hydrophobic domains.

A multilayer film for an ostomy pouch includes a barrier layer that is substantially impermeable to malodor causing compounds and arranged between outer layers. Each of the outer layers is formed from a polymeric mixture comprising about 90 wt.% to about 99 wt.% of a polar polymer and about 1 wt.% to about 10 wt.% of a slip agent and / or an anti-block agent, wherein the polymeric mixture is free of a non-polar polymer.

An ostomy pouch that has a cavity for containing human waste defined by a multilayer barrier film that has, in order from adjacent to the cavity outwards, an inner polymer carrier layer, an inner tie layer, a barrier layer comprising poly(ethylene-co-vinyl alcohol), an outer tie layer, and an outer polymer carrier layer. The tie layers each have recycled polymer material and at least one compatibilizer.

An ostomy pouch having a cavity for storing stomal output. The cavity is defined by a rear wall and a front wall joined at their peripheries and formed of flexible sheet material. The ostomy pouch further comprises a sheet of woven comfort material covering the outside surface of the front wall. The sheet of comfort material has an outside surface and an opposite inside surface, and the outside surface of the sheet of comfort material forms at least part of the outside surface of the pouch. The inside surface of the sheet of comfort material is laminated across its entire surface to a continuous layer of film material. At least part of the continuous layer of film material is adjacent, facing and unbonded to the outside surface of the front wall.

Embodiments include systems and methods for treating diseases of the bladder, kidneys and urinary tract. Drug products can be administered through the urethra in a compact form. Within the bladder, the products can expand or conform to a larger size which resists passage into the urethra over a desired residence period. After a treatment period, at least a portion of the products can dissolve or degrade so that individual particles are voided in the urine. Embodiments also include drug particle delivery devices and methods of intravesical administration. A delivery device can use a straw-shaped cartridge packed with rod-shaped products that are administered into the bladder of a patient by a pressure source or actuation of a piston. The distal end of the barrel can connect to a vesical sheath or a soft tip in order to plunge directly into a patient's urethra.

An ostomy appliance comprising a barrier and a pouch which is adhered to the barrier. The barrier is made of a material comprising a top layer, a reinforcing layer, and an adherent layer. The top layer comprises a base material and upper and lower piles extending from opposite surfaces of said base material. The reinforcing layer being secured to said top layer by a first binder which will bond to said reinforcing layer. The adherent layer comprising a silicone gel which is bonded to said reinforcing layer by a second binder.

A multilayer film for an ostomy pouch includes a barrier layer that is substantially impermeable to malodor causing compounds and arranged between outer layers. Each of the outer layers is formed from a polymeric mixture comprising about 90 wt.% to about 99 wt.% of a polar polymer and about 1 wt.% to about 10 wt.% of a slip agent and / or an anti-block agent, wherein the polymeric mixture is free of a non-polar polymer.

Compositions are disclosed herein comprising at least (a) a derivative of an alpha-glucan, wherein (i) at least about 40% of the glycosidic linkages of the alpha-glucan are alpha-1,6 linkages, and (ii) the alpha-glucan has a degree of substitution (DoS) of about 0.001 to about 3.0 with at least one positively charged organic group (optionally in ether linkage); and (b) an insoluble alpha-glucan, wherein at least about 50% of the glycosidic linkages of the insoluble alpha-glucan are alpha-1,3 glycosidic linkages, and the weight-average degree of polymerization (DPw) of the insoluble alpha-glucan is at least 10. The insoluble alpha-glucan can enhance the degree to which the alpha-glucan derivative deposits onto a fiber-containing material / article such as fabric, for example. Methods are further disclosed for preparing compositions comprising an alpha-glucan ether derivative, as well as various applications of using these compositions, such as for controlling microbes on fabric surfaces.

Embodiments include systems and methods for treating diseases of the bladder, kidney, and urinary tract. The pharmaceutical product may be administered through the urethra in compacted form. Within the bladder, the product may expand or conform to a larger size, which prevents access into the urethra within a desired residence period. After the treatment period, at least a portion of the product may be dissolved or degraded such that individual particles excrete with urine. Embodiments also include drug particle delivery devices and methods of intravesical administration. The delivery device may use a drug-loaded cannula cartridge filled with a rod-like product that is administered into the bladder of a patient by actuation of a pressure source or a piston. The distal end of the barrel may be connected to a bladder sheath or a soft tip for direct insertion into the urethra of the patient.

The present invention relates to an implant comprising at least one three-dimensional porous structural element of at least one synthetic polymer, wherein the at least one porous structural element is irreversibly attached to an implant element by means of at least one adhesive polymer, methods for preparing the same, and uses thereof.

A biodegradable odor barrier film for ostomy, continence and towel management applications includes a barrier layer comprising at least about 90% wt. polyglycoiic acid. The biodegradable odor barrier film provides excellent mechanical and odor barrier properties desired in ostomy, continence and bowel management applications.

An ostomy skin barrier is formed from a double network hydrogel (DN hydrogel) comprising at least two different polymer networks, such as a polyacrylamide network, a sodium alginate network, and chitosan network. The DN hydrogel can also include a pH biosensor configured to change color when exposed to stoma dejecta to indicate a leakage.

A multilayer film for an ostomy pouch includes a barrier layer that is substantially impermeable to malodor causing compounds and arranged between outer layers. Each of the outer layers is formed from a polymeric mixture comprising about 90 wt. % to about 99 wt. % of a polar polymer and about 1 wt. % to about 10 wt. % of a slip agent and / or an anti-block agent, wherein the polymeric mixture is free of a non-polar polymer.

The present invention provides a stoma skin barrier device comprising: a front side and a back side wherein at least a portion of the front side comprises a medical adhesive wherein the medical adhesive comprises at least one pre-gelatinized starch or pre-gelatinized modified starch; and an opening on the skin barrier device, the opening being capable of at least partially receiving a stoma in use.

A multilayer film for an ostomy pouch includes a barrier layer that is substantially impermeable to malodor causing compounds and arranged between outer layers. Each of the outer layers is formed from a polymeric mixture comprising about 90 wt.% to about 99 wt.% of a polar polymer and about 1 wt.% to about 10 wt.% of a slip agent and / or an anti-block agent, wherein the polymeric mixture is free of a non-polar polymer.

An ostomy skin barrier composition includes a water-insoluble pressure-sensitive adhesive component, a hydrophilic component, and at least three different types of lipids including ceramide, cholesterol, and fatty acids. The skin barrier composition is configured to provide skin barriers having adhesive characteristics suitable for ostomy applications to securely attach an ostomy pouch to user's peristomal skin, while minimizing peristomal skin irritation and injuries.

An absorbent insert for an ostomy appliance, the ostomy appliance comprising a wafer and a collection pouch, the insert comprising a single, cohesive absorbent body configured for placement within the collection pouch, the absorbent body being non-particulating in use, introducible in a compressed state, and swellable to an expanded state upon wetting, and an elongate tether attached to the absorbent body, wherein, in use, the absorbent body is operative to absorb and immobilize liquid within the lower region of the collection pouch, thereby forming a liquid-laden mass that is anchored by the tether to inhibit upward migration of effluent toward the wafer.

The skin care composition provides a skin care composition capable of interacting with enzymes in the stoma output, thereby reducing enzyme activity.SOLUTION: A skin care composition comprising at least 1 wt.% potato protein, a first binder comprising a polar or non-polar polymer or copolymer in an amount of 20 to 70 wt.%, and 20 to 80 wt.% solids.SELECTED DRAWING: None

An ostomy pouch having a cavity for storing stomal output. The cavity is defined by a rear wall and a front wall joined at their peripheries and formed of flexible sheet material. The ostomy pouch further comprises a sheet of woven comfort material covering the outside surface of the front wall. The sheet of comfort material has an outside surface and an opposite inside surface, and the outside surface of the sheet of comfort material forms at least part of the outside surface of the pouch. The inside surface of the sheet of comfort material is laminated across its entire surface to a continuous layer of film material. At least part of the continuous layer of film material is adjacent, facing and unbonded to the outside surface of the front wall.

The disclosed technology includes an ostomy appliance including a filter, the filter including a substrate at least partially coated with a sorbent material, the sorbent material including a basic copper sulphate such as brochantite. Also disclosed is an ostomy appliance including a filter, the filter including a substrate at least partially coated with a metal-containing sorbent material, wherein the sorbent material includes nanowires having a width of less than 50 nm. Also disclosed is a method for manufacturing an ostomy appliance including a filter, the method including drawing a sorbent material through a substrate by applying a pressure differential across the substrate; and attaching the substrate to an ostomy appliance.

An ostomy pouch that has a cavity for containing human waste defined by a multilayer barrier film that has, in order from adjacent to the cavity outwards, an inner polymer carrier layer, an inner tie layer, a barrier layer comprising poly(ethylene-co-vinyl alcohol), an outer tie layer, and an outer polymer carrier layer. The tie layers each have recycled polymer material and at least one compatibilizer.

An ostomy bag has a cavity defined by a multi-layer barrier film having an inner polymeric carrier layer, an inner adhesive layer, a barrier layer comprising poly (ethylene-co-vinyl alcohol), an outer adhesive layer, and an outer polymeric carrier layer in order from adjacent the cavity outward for containing human excreta. The bond layers each have a recycled polymeric material and at least one compatibilizer.

The invention relates to an antimicrobially active product, having: - a carrier and - a dihydrotriazine compound, a tautomer thereof, or a salt thereof, wherein the dihydrotriazine compound, the tautomer thereof, or the salt thereof is bonded to the carrier, and the dihydrotriazine compound has the following general formula I: formula (I), where - R1 represents (i) a phenyl group or a phenylalkyl group, each of which is optionally substituted with 1 to 3 substituents, selected from the group consisting of a C1-6-alkoxy group, a hydroxy group, a halogen atom, a C1-6-alkyl halide group, a C1-6-alkyl group, a sulfonamido group, and a C1-6-alkoxy halide group, (ii) a naphthyl group or a naphthyl alkyl group, (iii) a heterocyclic group, a heterocyclic alkyl group, or a heterocyclic aminoalkyl group, (iv) an alkyl group with 1 to 16 carbon atoms, or (v) a cycloalkyl group or a cycloalkyl-alkyl group, - R1' represents a hydrogen atom, bonded with the nitrogen atom at position 1 or 3 of the dihydrotriazine ring, - R2 and R3, independently of one another, represent a hydrogen atom or a methyl group, - R4 represents an alkyl group with 7 to 16 carbon atoms, and - the dashed line indicates that the position of a double bond is either between positions 1 and 2 or positions 2 and 3 of the dihydrotriazine ring.